Product Name

  • Name

    5-Fluorotryptamine

  • EINECS
  • CAS No. 576-16-9
  • Article Data21
  • CAS DataBase
  • Density 1.25 g/cm3
  • Solubility
  • Melting Point 273-275 °C
  • Formula C10H11FN2
  • Boiling Point 345.959 °C at 760 mmHg
  • Molecular Weight 178.209
  • Flash Point 163.03 °C
  • Transport Information
  • Appearance
  • Safety 26-36
  • Risk Codes 20/21/22-36/37/38
  • Molecular Structure Molecular Structure of 576-16-9 (5-Fluorotryptamine)
  • Hazard Symbols HarmfulXn, IrritantXi
  • Synonyms Indole,3-(2-aminoethyl)-5-fluoro- (6CI,7CI,8CI);2-(5-Fluoro-1H-indol-3-yl)ethylamine;2-(5-Fluoroindol-3-yl)ethylamine;
  • PSA 41.81000
  • LogP 2.50850

Synthetic route

5-fluoro-3-(2-nitrovinyl)indole
208645-53-8

5-fluoro-3-(2-nitrovinyl)indole

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; for 40h;92%
With lithium aluminium tetrahydride In tetrahydrofuran Reflux;
(Ε)-5-fluoro-3-(2-nitroethenyl)-1Η-indole
214417-26-2

(Ε)-5-fluoro-3-(2-nitroethenyl)-1Η-indole

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; Inert atmosphere;76%
With lithium aluminium tetrahydride In tetrahydrofuran for 5h; Ambient temperature;
With lithium aluminium tetrahydride In tetrahydrofuran at 20℃; for 5h;
DL-5-fluorotryptophan
154-08-5

DL-5-fluorotryptophan

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
With pyridoxal 5'-phosphate; aromatic L-amino acid decarboxylase In various solvent(s) at 30℃; for 48h;41%
With NH4OH-NH4Cl buffer; pyridoxal 5'-phosphate at 30℃; for 0.5h; relative rate of CO2 evolution by aromatic L-amino acid decarboxylase from Micrococcus percitreus;
5-fluoro-3-(2-nitroethyl)-1Η-indole

5-fluoro-3-(2-nitroethyl)-1Η-indole

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
Stage #1: 5-fluoro-3-(2-nitroethyl)-1Η-indole With ammonium chloride In tetrahydrofuran; ethanol at 85℃; for 0.166667h;
Stage #2: With iron
26.2%
3-(2-amino-ethyl)-5-fluoro-indole-2-carboxylic acid
1512-99-8

3-(2-amino-ethyl)-5-fluoro-indole-2-carboxylic acid

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
With hydrogenchloride
4-aminobutyrylaldehyde diethylacetal
6346-09-4

4-aminobutyrylaldehyde diethylacetal

4-fluorophenylhydrazine
371-14-2

4-fluorophenylhydrazine

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
With zinc(II) chloride at 180℃;
5-fluoro-1H-indole
399-52-0

5-fluoro-1H-indole

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: POCl3 / 0.25 h / 20 °C
1.2: CaCO3 / 1,2-dichloro-ethane / 0.5 h / Heating
2.1: 60 percent / ammonium acetate / 1.5 h / Heating
3.1: LiAlH4 / tetrahydrofuran / 5 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1: 1.) POCl3, 2.) CaCO3 / 1.) RT, 15 min, 2.) 1,2-dichloroethane, reflux, 30 min
2: 60 percent / ammonium acetate / 1.5 h / Heating
3: LiAlH4 / tetrahydrofuran / 5 h / Ambient temperature
View Scheme
Multi-step reaction with 3 steps
1.1: trichlorophosphate / 1.25 h / 0 - 38 °C
1.2: 0.08 h / 170 °C
2.1: ammonium acetate / 1.5 h / Reflux
3.1: lithium aluminium tetrahydride / tetrahydrofuran / 40 h / 0 - 20 °C
View Scheme
Multi-step reaction with 4 steps
1: diethyl ether / 3 h / 0 - 20 °C
2: diethyl ether / 1 h / 20 °C
3: ammonia / water / 24 h / 20 °C
4: lithium aluminium tetrahydride / tetrahydrofuran / 10 h / Reflux
View Scheme
5-fluoro-1H-indole-3-carbaldehyde
2338-71-8

5-fluoro-1H-indole-3-carbaldehyde

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 60 percent / ammonium acetate / 1.5 h / Heating
2: LiAlH4 / tetrahydrofuran / 5 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: 60 percent / ammonium acetate / 1.5 h / Heating
2: LiAlH4 / tetrahydrofuran / 5 h / Ambient temperature
View Scheme
Multi-step reaction with 2 steps
1: piperidine; acetic acid / benzene / Reflux
2: lithium aluminium tetrahydride / tetrahydrofuran / Reflux
View Scheme
Multi-step reaction with 2 steps
1: ammonium acetate / 1.5 h / Reflux
2: lithium aluminium tetrahydride / tetrahydrofuran / 40 h / 0 - 20 °C
View Scheme
piperidine-2,3-dione-3-(4-fluoro-phenylhydrazone)
721-58-4

piperidine-2,3-dione-3-(4-fluoro-phenylhydrazone)

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: aqueous HCl; acetic acid
2: aq.-ethanolic KOH
3: aqueous HCl
View Scheme
6-fluoro-2,3,4,9-tetrahydro-β-carbolin-1-one
778-73-4

6-fluoro-2,3,4,9-tetrahydro-β-carbolin-1-one

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aq.-ethanolic KOH
2: aqueous HCl
View Scheme
3-(2-nitroethyl)-6-fluoroindole
937256-55-8

3-(2-nitroethyl)-6-fluoroindole

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
With hydrazine; nickel In ethanol at 20℃; for 1h;
2-(3-chloropropyl)-1,3-dioxolane
16686-11-6

2-(3-chloropropyl)-1,3-dioxolane

4-fluorophenylhydrazine
371-14-2

4-fluorophenylhydrazine

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
In ethanol; water at 95℃; for 1h;
C15H19FN2O2

C15H19FN2O2

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
Stage #1: C15H19FN2O2 With trifluoroacetic acid In dichloromethane at 25℃; Inert atmosphere;
Stage #2: With sodium hydroxide In dichloromethane; water at 25℃; pH=Ca. 12 - Ca. 13; Inert atmosphere;
12.6 mg
With trifluoroacetic acid In dichloromethane at 0 - 25℃; Inert atmosphere;12.6 mg
C18H13FN2O2
1198292-69-1

C18H13FN2O2

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
With hydrazine In ethanol at 20℃; Combinatorial reaction / High throughput screening (HTS);
3-(2-azidoethyl)-5-fluoro-1H-indole
1258297-02-7

3-(2-azidoethyl)-5-fluoro-1H-indole

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In ethanol under 3102.97 Torr;
4-chloro-1-hydroxy-1-butanesulfonate sodium
54322-20-2

4-chloro-1-hydroxy-1-butanesulfonate sodium

4-fluorophenyhydrazine hydrochloride
823-85-8

4-fluorophenyhydrazine hydrochloride

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
With disodium hydrogenphosphate In ethanol at 70℃; for 6h;
4-fluoroaniline
371-40-4

4-fluoroaniline

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: sodium nitrite; hydrogenchloride / water / 1 h / 0 - 5 °C
1.2: 4 h / 80 - 100 °C
2.1: disodium hydrogenphosphate / ethanol / 6 h / 70 °C
View Scheme
C10H7FN2O2

C10H7FN2O2

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran for 10h; Reflux;
methyl 2-(5-fluoro-1H-indol-3-yl)-2-oxoacetate
408356-39-8

methyl 2-(5-fluoro-1H-indol-3-yl)-2-oxoacetate

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: ammonia / water / 24 h / 20 °C
2: lithium aluminium tetrahydride / tetrahydrofuran / 10 h / Reflux
View Scheme
2-(5-fluoro-1H-indol-3-yl)-2-oxoacetyl chloride
3828-09-9

2-(5-fluoro-1H-indol-3-yl)-2-oxoacetyl chloride

5-fluorotryptamine
576-16-9

5-fluorotryptamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: diethyl ether / 1 h / 20 °C
2: ammonia / water / 24 h / 20 °C
3: lithium aluminium tetrahydride / tetrahydrofuran / 10 h / Reflux
View Scheme
5-fluorotryptamine
576-16-9

5-fluorotryptamine

phenyl chloroformate
1885-14-9

phenyl chloroformate

[2-(5-fluoro-1H-indol-3-yl)-ethyl]-carbamic acid phenyl ester

[2-(5-fluoro-1H-indol-3-yl)-ethyl]-carbamic acid phenyl ester

Conditions
ConditionsYield
With pyridine In dichloromethane at 20℃; for 24h; Heating / reflux;100%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

tert-butyl N-[2-(5-fluoro-1H-indol-3-yl)ethyl]carbamate
1059175-54-0

tert-butyl N-[2-(5-fluoro-1H-indol-3-yl)ethyl]carbamate

Conditions
ConditionsYield
In 1,4-dioxane at 20℃; for 16h;99%
With triethylamine In tetrahydrofuran at 10℃; for 1h; Inert atmosphere;83%
With triethylamine In tetrahydrofuran at 10℃; for 1h;83%
formaldehyd
50-00-0

formaldehyd

5-fluorotryptamine
576-16-9

5-fluorotryptamine

2-(5-fluoro-1H-indol-3-yl)-N,N-dimethylethanamine
22120-36-1

2-(5-fluoro-1H-indol-3-yl)-N,N-dimethylethanamine

Conditions
ConditionsYield
With sodium acetate; sodium cyanoborohydride In methanol at 0 - 25℃; for 5h;97.3%
With sodium cyanoborohydride; acetic acid In methanol for 2h; pH=6.5; Reflux;
5-fluorotryptamine
576-16-9

5-fluorotryptamine

salicylaldehyde
90-02-8

salicylaldehyde

N-(2-hydroxyphenylmethyl)-2-(5-fluoro-3-indolyl)ethylamine

N-(2-hydroxyphenylmethyl)-2-(5-fluoro-3-indolyl)ethylamine

Conditions
ConditionsYield
Stage #1: 5-fluorotryptamine; salicylaldehyde In ethanol for 1h;
Stage #2: With sodium cyanoborohydride In ethanol
92.5%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

7-(trifluoromethyl)-3,4,5,6-tetrahydro-2H-azepine
1146222-77-6

7-(trifluoromethyl)-3,4,5,6-tetrahydro-2H-azepine

5-(6-fluoro-1-(trifluoromethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)pentan-1-amine

5-(6-fluoro-1-(trifluoromethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)pentan-1-amine

Conditions
ConditionsYield
With trifluoroacetic acid In dichloromethane at 20℃; for 168h; Pictet-Spengler Synthesis;90%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

5-(4-hydroxyphenyl)-2-furancarboxaldehyde
13130-10-4

5-(4-hydroxyphenyl)-2-furancarboxaldehyde

4-[5-({[2-(5-fluoro-1H-indol-3-yl)ethyl]amino}methyl)furan-2-yl]phenol

4-[5-({[2-(5-fluoro-1H-indol-3-yl)ethyl]amino}methyl)furan-2-yl]phenol

Conditions
ConditionsYield
Stage #1: 5-fluorotryptamine; 5-(4-hydroxyphenyl)-2-furancarboxaldehyde In methanol at 20℃; Molecular sieve;
Stage #2: With sodium tetrahydroborate In methanol for 1h; Molecular sieve;
82%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

(4-oxo-5-thiophen-2-ylmethylen-2-thioxothiazolidine-3-yl)acetyl chloride

(4-oxo-5-thiophen-2-ylmethylen-2-thioxothiazolidine-3-yl)acetyl chloride

N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-2-[(5Z)-4-oxo-5-thiophen-2-ylmethylen-2-thioxothiazolidin-3-yl]acetamide

N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-2-[(5Z)-4-oxo-5-thiophen-2-ylmethylen-2-thioxothiazolidin-3-yl]acetamide

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane for 0.5h; Heating;82%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

3-methylsalicylic acid
83-40-9

3-methylsalicylic acid

N-(2-(5-fluoro-1H-indol-3-yl)ethyl)-2-hydroxy-3-methylbenzamide

N-(2-(5-fluoro-1H-indol-3-yl)ethyl)-2-hydroxy-3-methylbenzamide

Conditions
ConditionsYield
Stage #1: 3-methylsalicylic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In acetone at 20℃; for 4h;
Stage #2: 5-fluorotryptamine In acetone at 20℃; for 24h;
79.43%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

2-hydroxy-p-toluic acid
50-85-1

2-hydroxy-p-toluic acid

N-(2-(5-fluoro-1H-indol-3-yl)ethyl)-2-hydroxy-4-methylbenzamide

N-(2-(5-fluoro-1H-indol-3-yl)ethyl)-2-hydroxy-4-methylbenzamide

Conditions
ConditionsYield
Stage #1: 2-hydroxy-p-toluic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In acetone at 20℃; for 4h;
Stage #2: 5-fluorotryptamine In acetone at 20℃; for 24h;
79.43%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

salicylic acid
69-72-7

salicylic acid

N-(2-(5-fluoro-1H-indol-3-yl)ethyl)-2-hydroxybenzamide

N-(2-(5-fluoro-1H-indol-3-yl)ethyl)-2-hydroxybenzamide

Conditions
ConditionsYield
Stage #1: salicylic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In acetone at 20℃; for 4h;
Stage #2: 5-fluorotryptamine In acetone at 20℃; for 24h;
78.23%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

tert-butyl 3-(2-((tert-butoxycarbonyl)amino)ethyl)-5-fluoro-1H-indole-1-carboxylate

tert-butyl 3-(2-((tert-butoxycarbonyl)amino)ethyl)-5-fluoro-1H-indole-1-carboxylate

Conditions
ConditionsYield
With dmap In dichloromethane at 0 - 20℃;77%
With dmap In dichloromethane at 0 - 20℃; for 1h;46%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

4-chlorosalicylic acid
5106-98-9

4-chlorosalicylic acid

4-chloro-N-(2-(5-fluoro-1H-indol-3-yl)ethyl)-2-hydroxybenzamide

4-chloro-N-(2-(5-fluoro-1H-indol-3-yl)ethyl)-2-hydroxybenzamide

Conditions
ConditionsYield
Stage #1: 4-chlorosalicylic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In acetone at 20℃; for 4h;
Stage #2: 5-fluorotryptamine In acetone at 20℃; for 24h;
75.54%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

5-phenylfuran-2(3H)-one

5-phenylfuran-2(3H)-one

(11bS)-8-fluoro-11b-phenyl-1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one
1178541-58-6

(11bS)-8-fluoro-11b-phenyl-1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one

Conditions
ConditionsYield
With (R)-3,3'-bis(triphenylsilyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate In toluene at 110℃; for 24h; optical yield given as %ee; enantioselective reaction;73%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

6-(trifluoromethyl)-2,3,4,5-tetrahydropyridine
1146222-76-5

6-(trifluoromethyl)-2,3,4,5-tetrahydropyridine

4-(6-fluoro-1-(trifluoromethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)butan-1-amine

4-(6-fluoro-1-(trifluoromethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)butan-1-amine

Conditions
ConditionsYield
With camphor-10-sulfonic acid In water at 130℃; for 14h; Pictet-Spengler Synthesis;73%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

bis(trichloromethyl) carbonate
32315-10-9

bis(trichloromethyl) carbonate

19-nor-Δ1,3,5(10)-22α-spirostatriene-3-ol
24036-91-7

19-nor-Δ1,3,5(10)-22α-spirostatriene-3-ol

(22R,25R)-3β-(5-fluoro-1H-indole-3-ethylamine-carboxylate)-1,3,5(10)-trien-20α-spirostan

(22R,25R)-3β-(5-fluoro-1H-indole-3-ethylamine-carboxylate)-1,3,5(10)-trien-20α-spirostan

Conditions
ConditionsYield
Stage #1: bis(trichloromethyl) carbonate; 19-nor-Δ1,3,5(10)-22α-spirostatriene-3-ol With N-ethyl-N,N-diisopropylamine In dichloromethane at 0℃; for 0.5h; Inert atmosphere;
Stage #2: 5-fluorotryptamine In dichloromethane at 20℃; for 3h; Inert atmosphere;
73%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

5-bromosalicyclic acid
89-55-4

5-bromosalicyclic acid

5-bromo-N-(2-(5-fluoro-1H-indol-3-yl)ethyl)-2-hydroxybenzamide

5-bromo-N-(2-(5-fluoro-1H-indol-3-yl)ethyl)-2-hydroxybenzamide

Conditions
ConditionsYield
Stage #1: 5-bromosalicyclic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In acetone at 20℃; for 4h;
Stage #2: 5-fluorotryptamine In acetone at 20℃; for 24h;
71.54%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

N-(2-(5-fluoro-1H-indol-3-yl)ethyl)-4-methylbenzenesulfonamide
1024493-18-2

N-(2-(5-fluoro-1H-indol-3-yl)ethyl)-4-methylbenzenesulfonamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 24℃; for 4h;71%
With triethylamine In dichloromethane at 0 - 20℃; for 6h;
With triethylamine In dichloromethane at 0℃;
With triethylamine In dichloromethane at 20℃; for 4h;
5-fluorotryptamine
576-16-9

5-fluorotryptamine

5-chloro-2-hydroxybenzoic acid
321-14-2

5-chloro-2-hydroxybenzoic acid

5-chloro-N-(2-(5-fluoro-1H-indol-3-yl)ethyl)-2-hydroxybenzamide

5-chloro-N-(2-(5-fluoro-1H-indol-3-yl)ethyl)-2-hydroxybenzamide

Conditions
ConditionsYield
Stage #1: 5-chloro-2-hydroxybenzoic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In acetone at 20℃; for 4h;
Stage #2: 5-fluorotryptamine In acetone at 20℃; for 24h;
70.54%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

Methoxyacetyl chloride
38870-89-2

Methoxyacetyl chloride

C13H15FN2O2
1292285-47-2

C13H15FN2O2

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 26℃; for 2h;68.2%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

methyl (2E)-3-(4-formylphenyl)acrylate
7560-50-1, 71093-79-3, 58045-41-3

methyl (2E)-3-(4-formylphenyl)acrylate

3-[4-[[[2-(5-fluoro-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-(2E)-2-propenoic acid methyl ester

3-[4-[[[2-(5-fluoro-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-(2E)-2-propenoic acid methyl ester

Conditions
ConditionsYield
With sodium tris(acetoxy)borohydride In tetrahydrofuran67%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

1-(3-chloro-5-(trifluoromethyl)pyrid-2-yl)-4-piperidone
339029-35-5

1-(3-chloro-5-(trifluoromethyl)pyrid-2-yl)-4-piperidone

C21H19ClF4N4

C21H19ClF4N4

Conditions
ConditionsYield
Stage #1: 5-fluorotryptamine; 1-(3-chloro-5-(trifluoromethyl)pyrid-2-yl)-4-piperidone In chloroform for 1h; Molecular sieve; Heating / reflux;
Stage #2: With hydrogenchloride; water In chloroform Heating / reflux;
Stage #3: With sodium hydrogencarbonate In chloroform; water
67%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

1-((6-bromo-5-methylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxylic acid

1-((6-bromo-5-methylimidazo[1,2-a]pyridin-2-yl)methyl)-1H-1,2,3-triazole-4-carboxylic acid

1-((6-bromo-5-methylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-(5-fluoro-1H-indol-3-yl)ethyl)-1H-1,2,3-triazole-4-carboxamide

1-((6-bromo-5-methylimidazo[1,2-a]pyridin-2-yl)methyl)-N-(2-(5-fluoro-1H-indol-3-yl)ethyl)-1H-1,2,3-triazole-4-carboxamide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 25℃; for 3h;66%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

N,N-dimethyl-4-oxopiperidinium iodide
26822-37-7

N,N-dimethyl-4-oxopiperidinium iodide

1-[2-(5-fluoro-1H-indol-3-yl)-ethyl]-piperidin-4-one
151191-79-6

1-[2-(5-fluoro-1H-indol-3-yl)-ethyl]-piperidin-4-one

Conditions
ConditionsYield
With potassium carbonate In ethanol65%
5-fluorotryptamine
576-16-9

5-fluorotryptamine

2-trifluoromethyl-Δ1-pyrroline

2-trifluoromethyl-Δ1-pyrroline

3-(6-fluoro-1-(trifluoromethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)propan-1-amine

3-(6-fluoro-1-(trifluoromethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)propan-1-amine

Conditions
ConditionsYield
With camphor-10-sulfonic acid In water at 130℃; for 14h; Pictet-Spengler Synthesis;63%
but-3-yne-1-sulfonyl chloride

but-3-yne-1-sulfonyl chloride

5-fluorotryptamine
576-16-9

5-fluorotryptamine

N-[2-(5-fluoro-1H-indol-3-yl)ethyl]but-3-yne-1-sulfonamide
1452838-28-6

N-[2-(5-fluoro-1H-indol-3-yl)ethyl]but-3-yne-1-sulfonamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at -78℃; Inert atmosphere;57%
(4-dimethylamino-4-phenyl-cyclohexylmethyl)-carbamic acid phenyl ester
695212-95-4

(4-dimethylamino-4-phenyl-cyclohexylmethyl)-carbamic acid phenyl ester

5-fluorotryptamine
576-16-9

5-fluorotryptamine

1-(4-dimethylamino-4-phenyl-cyclohexylmethyl)-3-[2-(5-fluoro-1H-indol-3-yl)-ethyl]-urea

1-(4-dimethylamino-4-phenyl-cyclohexylmethyl)-3-[2-(5-fluoro-1H-indol-3-yl)-ethyl]-urea

Conditions
ConditionsYield
In 1,4-dioxane for 24h; Heating / reflux;56%
In 1,4-dioxane for 24h; Heating / reflux;
(4,6-dimethylpyrimidin-2-yl)cyanamide
55474-90-3

(4,6-dimethylpyrimidin-2-yl)cyanamide

5-fluorotryptamine
576-16-9

5-fluorotryptamine

3-{2-[((4,6-dimethylpyrimidin-2-ylamino)(imino)methyl)amino]ethyl}-5-fluoro-1H-indole

3-{2-[((4,6-dimethylpyrimidin-2-ylamino)(imino)methyl)amino]ethyl}-5-fluoro-1H-indole

Conditions
ConditionsYield
In 1,4-dioxane Heating;53%
2-methylmorpholine
27550-90-9

2-methylmorpholine

5-fluorotryptamine
576-16-9

5-fluorotryptamine

4-nitrobenzyl chloroformate
4457-32-3

4-nitrobenzyl chloroformate

N-(p-Nitrobenzyloxycarbonyl)-5-fluorotryptamine
163885-14-1

N-(p-Nitrobenzyloxycarbonyl)-5-fluorotryptamine

Conditions
ConditionsYield
In dichloromethane53%

5-FLUOROTRYPTAMINE Chemical Properties

Product Name: 5-Fluorotryptamine
CAS: 576-16-9
Formula: C10H11FN2
Structure of  5-Fluorotryptamine(576-16-9 ):
       
Molecular weight: 178.21
Boiling point: 346 °C at 760 mmHg
Density: 1.249 g/cm
Flash point: 163 °C
Index of refraction: 1.643
Molar refractivity: 51.6 cm3 
Molar volume: 142.5 cm
Polarizability: 20.45 10-24cm
Surface tension: 52.3 dyne/cm 
Enthalpy of vaporization: 59.01 kJ/mol 
Vapour pressure: 5.95E-05 mmHg at 25°C 
Water solubility: 3.2e+004(mg/L) at 25 °C 
The chemical synonyms of 5-Fluorotryptamine( 576-16-9 ) are 5-FLUOROTRYPTAMINE;AKOS B030092;3-(2-AMINOETHYL)-5-FLUORO-1H-INDOLE;2-(5-FLUORO-1H-INDOL-3-YL)-ETHYLAMINE;RARECHEM AN KA 1417;3-(2-Aminoethyl)-5-fluoro-1H-indole hydrochloride;5-FLUOROTRYPTAMINE,HPLC 98%.
The classification of 5-Fluorotryptamine ( 576-16-9 ) are: Indole/indoline/oxindole;Indole and Indoline;Indoline & Oxindole;Indole.

5-FLUOROTRYPTAMINE Safety Profile

Safety information about 5-Fluorotryptamine ( 576-16-9 ):
Hazard Codes
Xi:
Xn:   
Risk statements about 5-Fluorotryptamine .
R20/21/22: Harmful by inhalation, in contact with skin and if swallowed .
R36/37/38: Irritating to eyes, respiratory system and skin .
Safety statements about 5-Fluorotryptamine .
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36: Wear suitable protective clot.
Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View